EdgarLookup

Aprea Therapeutics, Inc. — DEFA14A Filings

4 DEFA14A filings on record

This page lists all DEFA14A filings submitted to the SEC by Aprea Therapeutics, Inc. (APRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aprea Therapeutics, Inc. has filed 4 DEFA14A documents with the SEC since 2019. To view all SEC filings by Aprea Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 4 424B3 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP PRE 14A S-1 S-1/A S-1MEF S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
DEFA14A DEFA14A 0001558370-25-005145 Apr 22, 2025 —
DEFA14A DEFA14A 0001558370-24-005683 Apr 25, 2024 —
DEFA14A DEFA14A 0001558370-21-005110 Apr 28, 2021 —
DEFA14A DEFA14A 0001558370-20-004661 Apr 29, 2020 —